EDOGHOGHO EDOSONMWAN: Open Payments
NPI 1356808901 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 11 payments from 5 companies in 2025. Trend: 2023 $29 · 2024 $739 · 2025 $478
Food & beverage: $478
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $175 |
| Neurocrine BioSciences, Inc. | 1 | $135 |
| Supernus Pharmaceuticals, Inc. | 1 | $87 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: VRAYLAR, INGREZZA, Qelbree, CAPLYTA, REXULTI.
Industry payments across TX — which companies pay providers there.
